C erviCal spondylotic myelopathy can be surgically treated by a variety of techniques, including both ventral and dorsal decompression with fusion. The ventral approach refers to multilevel discectomy and/or corpectomy with instrumented fusion, whereas the dorsal approach refers to midline cervical laminectomy and fu sion. 8, 18 Each of these approaches has unique advantages and disadvantages. Although a dorsal approach is techni cally easier and avoids the morbidity associated with a ventral approach, it can cause significant postoperative muscular pain and is limited to patients who have either neutral or lordotic alignment. A ventral approach allows for direct decompression of ventral pathological entities in kyphotic, neutral, or lordotic spines, and avoids the pain associated with a posterior paraspinal musculature stripping approach, but is associated with its own compli cations including dysphagia, hoarseness, and cardiopul monary events. 1, 4, 5, 10, 21 Traditional postoperative outcome measures such as complications, readmission rates, revision surgery rates, and return to work measures do not fully encompass the patient experience following surgery and the relative ad vantages and disadvantages of each of the approaches. Recent studies have increasingly investigated financial cost and QOL outcomes for these 2 surgeries. 1, 3, 5, 9, 22 Despite the numerous studies on this topic, uncer tainty remains about which of the 2 procedures is optimal for the treatment of CSM. Previous reviews on the topic, including one in this journal, 13 have attempted to address this uncertainty by using physiological parameters and other preoperative factors that may aid in the selection of the optimal surgical approach. Decisionmaking algo rithms have also been suggested based on the location of the stenosis and alignment of the cervical spine.
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Ventral fusion versus dorsal fusion: determining the optimal treatment for cervical spondylotic myelopathy
Methods
A MEDLINE review of Englishlanguage literature was performed to identify studies comparing ventral multilevel discectomy and fusion with dorsal cervical fu sion performed between 2003 and 2013. This time pe riod was chosen to focus on only the most recent stud ies relevant to current clinical practice. The search terms included ventral cervical fusion, anterior cervical fusion, dorsal cervical fusion, posterior cervical fusion, cervical spondylotic myelopathy, and CSM. A total of 3512 results were retrieved from these searches. Furthermore, refer ences from the identified studies as well as those from other review papers were used to ensure completeness. Studies were excluded if they did not pertain to ventral and dorsal fusion, involved singlelevel fusions, or if they were animal studies, single case reports, or clinical series with fewer than 10 patients reported, to ensure sufficient statistical power in study conclusions. Patients treated with laminectomy without fusion, and those who under went laminoplasty procedures were not included because the primary focus of this review was on fusion. Studies were included only if they specifically pertained to clini cal outcomes, complication profiles, or financial costs for ventral versus dorsal fusion surgery for CSM. Seven clinical studies were reviewed here.
Articles were further classified according to the level of evidence outlined by Resnick et al., 17 in which stud ies are categorized into 3 classes. Class I evidence is the highest level, consisting of randomized controlled trials. Class II evidence includes most prospective studies other than randomized controlled trials. Class III studies con sist of retrospectively collected data and case series. The level of evidence for the included studies was assessed by 2 independent reviewers (M.D.A. and D.L.), and any dis agreement was resolved by reviewer consensus. Data col lected from the included studies consisted of study type, patient sample size, specific complications and complica tion rate, health outcomes measured, types of question naires used, followup period, and costs.
Results
Seven studies (1 prospective, 6 retrospective) con sisting of 248,029 patients were identified and reviewed. Table 1 provides a summary of QOL outcomes assessed for the 2 procedures, Table 2 summarizes complications for each approach, and Table 3 summarizes the financial costs and costeffectiveness studies associated with each approach.
Studies of QOL Outcomes
Three studies (1 prospective, 2 retrospective) consist ing of 192 patients undergoing ventral (n = 114), dorsal (n = 72), or ventral and dorsal (n = 6) fusion surgery for CSM were analyzed (Table 1) . Outcome measures included the SF36, SF6D, EQ5D, mJOA, and NDI. All 3 studies had a 1-year follow-up and reported significantly (p < 0.05) improved QOL outcomes for some or all of these ques tionnaires from the preoperative to postoperative period.
Of these studies, the highest level of evidence was in the investigation by Ghogawala et al., 5 who conducted a prospective study on patients (n = 50) with CSM undergo ing either ventral (n = 28) or dorsal (n = 22) fusion. Both cohorts showed significant preoperative to postoperative improvement in mJOA (ventral: 2-point increase, p < 0.01; dorsal: 1.9-point increase, p < 0.01); EQ-5D (ventral: 0.16-point increase, p < 0.01; dorsal: 0.13-point increase, p = 0.04); and SF36 scores (ventral: 9.9point increase, p < 0.01; dorsal: 5.7-point increase, p = 0.03). In addi tion, the ventral cohort showed significant preoperative to postoperative improvement in the NDI score (18.4point decrease, p < 0.01), and had significantly greater improve ments only in the SF36 score compared with the dorsal cohort. Although greater improvement for the SF36 score was observed after ventral fusion, the dorsal cohort had a greater degree of myelopathy preoperatively than the ventral cohort, which may have confounded the results. In addition, the dorsal cohort on average had more levels surgically treated (3.1 vs 2.1 for ventral, p < 0.01) and was associated with a longer hospital stay (4 days vs 2.6 days) compared with the ventral cohort. Overall, both ventral and dorsal fusion surgery for CSM showed significant improvement in disease-specific symptoms and in QOL measures. The investigators concluded that a randomized controlled trial was needed to determine more accurately the optimal fusion approach for patients with CSM.
In 2012, Fehlings et al. 3 conducted a retrospec tive study of patients with CSM who were included in the AOSpine North America Cervical Spondylotic My elopathy Study (n = 70 cases; 45 patients in the ventral fusion cohort and 19 in the dorsal fusion cohort; 6 pa tients had both). The QOL outcomes measured by the mJOA (3point increase), NDI (11point decrease), SF36 (5point increase), and SF6D (0.07point increase) all showed significant (p < 0.0001) improvement by 1 year postoperatively. Thus, in agreement with Ghogawala et al., they found that surgical management of CSM produc es significantly improved QOL outcomes. However, this study did not make specific comparisons between ventral and dorsal fusion cohorts.
Also in 2012, Whitmore et al. 22 conducted a retro spective study on patients with CSM undergoing either ventral (n = 41) or dorsal (n = 31) fusion surgery. The ventral cohort had a greater, but statistically nonsignifi cant, improvement in both SF36 (ventral fusion cohort: 8.5point increase vs dorsal fusion cohort: 4.7point in crease) and NDI scores (ventral fusion cohort: 16.3point decrease vs dorsal fusion cohort: 10.8point decrease) compared with the dorsal cohort. No significant differ ences between the cohorts were identified for EQ-5D scores. Thus, in contrast to the study by Ghogawala et al., Whitmore and colleagues did not identify significant differences between ventral and dorsal cohorts. Further research is necessary to determine if true differences in QOL outcomes exist following ventral versus dorsal fu sion surgery for patients with CSM.
Studies of Complications
Four studies (1 prospective, 3 retrospective) consist ing of 235,549 patients undergoing ventral (n = 46,766) or dorsal (n = 8241) fusion surgery for CSM were analyzed ( Table 2 ). The overall complication rate ranged from 6.5% to 16.6%. Complication rates for ventral fusion sur gery ranged from 11% to 13.6%, whereas those for dorsal fusion surgery ranged from 16.4% to 19%. Complica tions included hoarseness, cardiopulmonary dysfunction, dysphagia, wound infection, sensory loss, weakness, and death. Patients who underwent multilevel ventral decom pression and fusion had a higher rate of hoarseness and dysphagia, whereas those who underwent dorsal fusions had a higher rate of neck pain or nerve palsies.
In 2007, Wang et al. 21 used the NIS to retrospectively review the medical records of 932,009 patients who un derwent cervical spine surgery for degenerative disease (19% with CSM) between 1992 and 2001. Patients with CSM who underwent surgery had the highest complica tion rate (6.5%) and inhospital mortality rate (0.39%) compared with the rates for other types of cervical spine surgery.
Boakye et al. 1 also used the NIS database to review 58,115 patients with CSM undergoing surgery between 1993 and 2002. These investigators reported an over all complication rate of 13.4% (16.4% for dorsal fusion, 11.9% for ventral fusion; no p value reported). Pulmonary (3.6%) and postoperative hemorrhages or hematomas (2.3%) were the most common complications for both ventral and dorsal fusion. Dysphagia (3%) and hoarse ness (0.21%) were more prevalent in the ventral cohort. Pulmonary complications (4.6%) and hematomas (3.22%) were more prevalent in the dorsal cohort. Other compli cations for both cohorts included renal (1.45%), cardiac (1.2%), thromboembolic (0.73%), neurological (0.71%), and infection (0.43%). Ghogawala et al. 5 showed that complication profiles did not significantly differ between ventral and dorsal cohorts (13.6% vs 17.9% for ventral and dorsal approach cohorts, respectively; p = 1.0). The overall complication rate was 16.6%. The dorsal cohort had greater rates of postoperative pain and disability compared with the ven 4 analyzed 302 patients from the AOSpine North America Cervical Spondylotic Myelopa thy Study who underwent surgical treatment for CSM. These investigators reported an overall perioperative complication (for example, infection, bleeding, dural tear, esophageal injury) rate of 15.6%, with an overall delayed complication (for example, pseudarthrosis, hardware breakage, graft dislodgement) rate of 4.4%. The ventral and dorsal cohorts had complication rates of 11% and 19%, respectively (p = 0.11). The most common compli cations included cardiopulmonary (3%), dysphagia (3%), and wound infection (2.3%). Operative blood loss was significantly (p < 0.01) greater in the dorsal cohort com pared with the ventral cohort. The dorsal cohort also had a significantly (p = 0.03) greater incidence of wound in fection (4.7%) compared with the ventral cohort (0.6%).
Studies of Cost-Effectiveness
Five studies (1 prospective, 4 retrospective) consist ing of 70,645 patients undergoing ventral (n = 57,125) or dorsal (n = 8365) fusion surgery for CSM were analyzed (Table 3) . Of these 5 studies, the 4 that included cohorts of ventral versus dorsal fusion surgery all showed that costs were greater for dorsal when compared with ventral fu sion surgery.
Fehlings et al. 3 calculated the financial costs and costeffectiveness of both ventral and dorsal fusion surgery for patients with CSM. Direct costs on average for both fu sion surgeries were $21,066 Canadian ($20,516 US). The costutility ratio was $32,916 Canadian/QALY gained, allowing the investigators to conclude that surgical man agement of CSM is costeffective based on thresholds for costeffectiveness in the literature.
Boakye et al. 1 used data from the NIS database to estimate an average total cost of both ventral and dor sal fusion surgery for CSM to be $25,419. Dorsal fusion surgery had significantly greater costs ($30,927) than ventral fusion surgery ($23,209). King et al. 9 performed a retrospective review of the Washington State Inpatient Database (1998-2002) that used a published algorithm for identifying cervical spine surgery admissions related to cervical spine degenerative disease (not CSM specific). Hospital charges were significantly (p < 0.01) greater for dorsal ($23,400) compared with ventral ($14,300) fusion surgery (2.3year mean followup).
Similarly, Ghogawala et al. 5 showed that dorsal fu sion surgery was associated with significantly greater costs ($29,465) than ventral fusion surgery ($19,245) in a 1year followup. Costs were derived by combining Medi care reimbursements or costtocharge ratios with actual hospital charges.
Whitmore et al. 22 also conducted a cost analysis by using 2 different cost calculation methodologies: cost tocharge ratios and Medicare reimbursement. Using the former, the investigators found that dorsal fusion sur gery had significantly (p = 0.02) greater costs ($27,942) compared with ventral fusion surgery ($21,563). Because the costs of ventral fusion were less than those of dor sal fusion, the calculated incremental costeffectiveness ratio for ventral fusion was negative and, thus, was said to be "dominated" by ventral fusion. In contrast, when using the Medicare reimbursement calculations the costs were not significantly different (dorsal: $16,579, ventral: $17,538), and the incremental costeffectiveness ratio for ventral fusion was $34,533/QALY gained. This study highlighted how different conclusions can be reached relative to cost-effectiveness or significant differences in cost depending on which cost methodology is used. Nota bly, there is much heterogeneity in the literature regarding methods by which both "costs" and "costeffectiveness" have been measured to date.
Discussion
Patients with CSM commonly present with vary ing patterns of trunk or extremity numbness, neck pain, loss of hand dexterity, motor weakness in the upper ex tremities, and gait disturbances. 11, 16 Although the first-line treatment in the majority of patients is conservative man agement (including cervical immobilization via a neck collar or brace and physical therapy 11, 16 ), surgical decom pression and/or fusion is often indicated in patients with progressive neurological demise with correlative spinal cord compression. There are various surgical techniques that are commonly used. The choice of surgical proce dure will vary based on the individual patients, the region of pathology, number of levels involved, cervical align ment, presence or absence of neck pain, and surgeon pref erence. In all patients, however, the goal of the surgery is to decompress the spinal cord, preserve alignment and stability of the spinal column, and prevent further injury.
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Regardless of the approach, early operative intervention can lead to superior outcomes. Suri et al. 19 showed in a prospective study of 146 patients that those with less than a 1-year duration of symptoms had significantly superior outcomes postoperatively (that is, motor/sensory/auto nomic/disability improvement) compared with those who had a longer duration of symptoms.
The present review demonstrated that both ventral and dorsal fusion result in significantly improved postoperative QOL compared with preoperatively. The 2 studies 5,22 that compared QOL outcomes for ventral versus dorsal fusion surgery demonstrated that ventral fusion leads to superior results, although in only one of these studies were these findings statistically significant. 5 Limitations of the studies included retrospective study design, small patient samples, and short followup time (1 year). More prospective, well designed studies are needed for better clarification of the QOL outcomes of these surgeries.
In addition, the included studies suggest that the complication rates and costs are significantly greater for dorsal fusion compared with ventral fusion. However, the complication rates for ventral fusion are also high and must be considered when consulting patients. To explain the cost differences between the 2 procedures, Whit more et al. 22 showed that there were significantly higher in-hospital charges for dorsal fusion. The Boakye et al., 1 King et al., 9 and Ghogawala et al. 5 studies do not provide detailed descriptions of their cost data or explanations for this difference, and this makes it difficult to accurately assess and make comparisons between the groups in these studies regarding "costs." The costs of some of the studies reviewed here did not include all relevant direct costs, including outpatient imaging technician fees or physical therapy and rehabilitation fees, or indirect costs to patients, such as loss of productivity and caregiver costs. Future costeffectiveness analyses should include detailed descriptions of the cost differences for a better explanation of the true costeffectiveness differences be tween ventral and dorsal fusion for CSM.
Many of the studies reviewed here focused exclusive ly on statistically significant differences and did not as certain clinical relevance. Clinically significant meaning has become increasingly important in assessing treatment options. The MCID for anterior cervical discectomy and fusion (ventral fusion) has recently been investigated by Parker et al. 15 The MCID represents the critical thresh old necessary to achieve treatment effectiveness and be beneficial to the patient. Many studies have evaluated the MCID for the questionnaires used in the studies discussed herein, including the visual analog scale, NDI, and EQ 5D. 2, 6, 23, 24 The reported MCID will be different depend ing on the type of procedure (for example, ventral and dorsal fusion). By identifying the clinically meaningful improvements for each of these surgeries (that is, based on patient reports of QOL), investigators will be better able to ascertain costeffectiveness and to comparative the effectiveness of the 2 procedures.
We acknowledge certain limitations that must be con sidered when interpreting the results of the present review. First, as in any systematic review, we include data from multiple studies and multiple surgeons with differing tech niques and data collection and reporting methods. These differences, including differences in the reporting of ma jor and minor complications, may somewhat confound the overall results. Second, nearly all of these studies represent Class III evidence, which is mainly retrospective. Studies of this design type may not account for differences in the patient sample with regard to comorbidities or the num ber of levels that were surgically treated. Wang et al. 21 and Boakye et al. 1 in particular used the NIS, which is the larg est publicly available inpatient care database in the US, updated annually, with approximately 8 million hospital stays. Databases of this nature may be associated with sig nificant sampling bias and coding errors that can confound results. The clinical data reviewed represent the low quality of evidence currently available and indicate the need for more welldesigned prospective studies of this commonly encountered disease process.
In 2009, Mummaneni et al. 12 performed a system atic review to compare the efficacy of different surgical techniques, including ventral and dorsal fusion, for the treatment of CSM. The investigators found insufficient evidence to recommend ventral fusion over dorsal fu sion because both produced comparable improvement in patients with CSM. Notably, this conclusion was based on Class III evidence, most of which was published more than 10 years ago, none of which incorporated cost or QOL data. Their study further supports the need for stud ies with better levels of evidence that include cost and QOL outcomes.
Finally, studies focusing solely on ventral corpectomy and fusion or laminoplasty were not included. Compared with multilevel discectomy and fusion, ventral corpec tomy has been shown to have higher complication rates, including graft dislodgements and fusion failure. 7, 18, 20 However, ventral corpectomy has been shown to yield similar QOL outcomes to ventral multilevel discectomy and fusion and, thus, should be investigated further in the future. 12 In addition to ventral and dorsal fusion, lamino plasty is also commonly used in the surgical treatment of patients with CSM. This approach leads to comparable postoperative improvement in CSM symptoms and has a complication rate of approximately 12%, which is within the same range as ventral and slightly below that of dor sal fusion. 4, 12 Despite these limitations, the present review summarizes the current state of the literature published over the past decade and offers guidance to future re search on the topic.
Conclusions
We have summarized the studies from the past de cade and have found that both ventral and dorsal fusion surgeries lead to significantly improved QOL outcomes in patients with CSM. Controversy remains regarding the preferred surgery for this patient population. Recent studies have shown that dorsal fusion has both a higher complication rate and costs significantly more than ven tral fusion. Most of the studies we reviewed, however, were Class III evidence, and therefore prospective stud ies are needed for a better comparison of the outcomes of the 2 surgical procedures. Furthermore, a greater fo cus on MCID values and clinically relevant findings is needed, to supplement the traditional use of statistical significance. Finally, cost-effectiveness analyses need to be more comprehensive (including more of the indirect costs) to understand better the true costs, costeffective ness, and comparative effectiveness of ventral versus dor sal fusion for CSM.
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